RIBAVIRIN — all Canadian products
19 DINs
1 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is RIBAVIRIN, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02170140 | VIRAZOLE | BAUSCH HEALTH, CANADA INC. | Powder For Solution; Aerosol | Inhalation | RIBAVIRIN 6 G | Marketed | |
| 02439212 | IBAVYR | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Tablet | Oral | RIBAVIRIN 200 MG | Dormant | |
| 02425890 | IBAVYR | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Tablet | Oral | RIBAVIRIN 400 MG | Dormant | |
| 02425904 | IBAVYR | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Tablet | Oral | RIBAVIRIN 600 MG | Dormant | |
| 02436418 | MODERIBA | ABBVIE CORPORATION | Tablet | Oral | RIBAVIRIN 400 MG | Cancelled Post Market | |
| 02436396 | MODERIBA | ABBVIE CORPORATION | Tablet | Oral | RIBAVIRIN 200 MG | Cancelled Post Market | |
| 02436426 | MODERIBA | ABBVIE CORPORATION | Tablet | Oral | RIBAVIRIN 600 MG | Cancelled Post Market | |
| 02254638 | PEGETRON | MERCK CANADA INC | Capsule; Powder For Solution | Oral; Subcutaneous | RIBAVIRIN 200 MG; PEGINTERFERON ALFA-2B 120 MCG | Cancelled Post Market | |
| 02254646 | PEGETRON | MERCK CANADA INC | Powder For Solution; Capsule | Oral; Subcutaneous | RIBAVIRIN 200 MG; PEGINTERFERON ALFA-2B 150 MCG | Cancelled Post Market | |
| 02246030 | PEGETRON | MERCK CANADA INC | Powder For Solution; Capsule | Subcutaneous; Oral | RIBAVIRIN 200 MG; PEGINTERFERON ALFA-2B 150 MCG | Cancelled Post Market | |
| 02246026 | PEGETRON | MERCK CANADA INC | Powder For Solution; Capsule | Oral; Subcutaneous | RIBAVIRIN 200 MG; PEGINTERFERON ALFA-2B 50 MCG | Cancelled Post Market | |
| 02246027 | PEGETRON | MERCK CANADA INC | Capsule; Powder For Solution | Oral; Subcutaneous | RIBAVIRIN 200 MG; PEGINTERFERON ALFA-2B 80 MCG | Cancelled Post Market | |
| 02246028 | PEGETRON | MERCK CANADA INC | Powder For Solution; Capsule | Subcutaneous; Oral | RIBAVIRIN 200 MG; PEGINTERFERON ALFA-2B 100 MCG | Cancelled Post Market | |
| 02246029 | PEGETRON | MERCK CANADA INC | Capsule; Powder For Solution | Oral; Subcutaneous | RIBAVIRIN 200 MG; PEGINTERFERON ALFA-2B 120 MCG | Cancelled Post Market | |
| 02254581 | PEGETRON | MERCK CANADA INC | Capsule; Powder For Solution | Oral; Subcutaneous | RIBAVIRIN 200 MG; PEGINTERFERON ALFA-2B 80 MCG | Cancelled Post Market | |
| 02254603 | PEGETRON | MERCK CANADA INC | Powder For Solution; Capsule | Oral; Subcutaneous | RIBAVIRIN 200 MG; PEGINTERFERON ALFA-2B 100 MCG | Cancelled Post Market | |
| 02239730 | REBETRON READY TO USE SOLUTION (ALBUMIN(HUMAN)FREE) (6000000 IU/ML AND 200MG CAPSULES) | SCHERING-PLOUGH CANADA INC | Kit; Capsule; Liquid | Oral; Subcutaneous | RIBAVIRIN 200 MG; INTERFERON ALFA-2B 6000000 UNIT | Cancelled Post Market | |
| 02241159 | REBETRON SOLUTION (ALBUMIN (HUMAN) FREE) (18 MIU MULTI-DOSE PEN / 200MG CAPSULES) | SCHERING-PLOUGH CANADA INC | Liquid; Capsule; Kit | Oral; Subcutaneous | RIBAVIRIN 200 MG; INTERFERON ALFA-2B 15000000 UNIT | Cancelled Post Market | |
| 00704008 | VIRAZOLE PWS 6GM/VIAL | VIRATEK INC. | Powder For Solution; Aerosol | Inhalation | RIBAVIRIN 6 G | Cancelled Post Market |
Browse other molecules: